Form 4 for NBIX NEUROCRINE BIOSCIENCES INC
Accepted 2022-09-09 00:00:00 ET · period of report 2022-09-07 · accession 0001209191-22-049330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-09 | 2022-09-07+ | NBIX | Lippoldt Darin | CLO | G - Gift | $0.00 | -200 | 29.3K | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-08 | G | D | 100 | $0.00 | 29,234 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-07 | G | D | 100 | $0.00 | 29,334 | D | — | — | (F1) Includes an aggregate of 38 shares purchased on August 31, 2022 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan. |